EUVIMEDEUVIMED entdecken
Crossref

Glucocorticoids as a risk factor for infection and adverse outcomes in non‐HIV and non‐transplant patients with cryptococcal meningitis

Luke Kim iD, Carolina Ferraz, Michaele Francesco Corbisiero, Sarah Gorvetzian, Carlos Franco-Paredes, Martin Krsak, Leland Shapiro, George R Thompson iD, Daniel B Chastain iD, Jose Tuells iD, Andrés F Henao-Martínez iD

Mycoses · 2024-03 · 67 (3)

DOI: 10.1111/myc.13709 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mycoses, 2024-03. Verfasst von Luke Kim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Meningitis, Cryptococcal, Cryptococcus, AIDS-Related Opportunistic Infections, HIV Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cryptococcal meningitis (CM), an opportunistic fungal infection affecting immunocompromised hosts, leads to high mortality. The role of previous exposure to glucocorticoids as a risk factor and as an outcome modulator has been observed, but systematic studies are lacking.

Objective

The primary aim of this study is to evaluate the impact of glucocorticoid use on the clinical outcomes, specifically mortality, of non‐HIV and non‐transplant (NHNT) patients diagnosed with CM.

Methods

We queried a global research network to identify adult NHNT patients with CM based on ICD codes or recorded specific Cryptococcus CSF lab results with or without glucocorticoid exposure the year before diagnosis. We performed a propensity score‐matched analysis to reduce the risk of confounding and analysed outcomes by glucocorticoid exposure. We used a Cox proportional hazards model for survival analysis.

Results

We identified 764 patients with a history of glucocorticoid exposure and 1267 patients without who developed CM within 1 year. After propensity score matching of covariates, we obtained 627 patients in each cohort. The mortality risk in 1 year was greater in patients exposed to prior glucocorticoids (OR: 1.3, CI: 1.2–2.0, p = 0.002). We found an excess of 45 deaths among CM patients with previous glucocorticoid use (7.4% increased absolute risk of dying within 1 year of diagnosis) compared to CM controls without glucocorticoid exposure. Hospitalisation, intensive care unit admission, emergency department visits, stroke and cognitive dysfunction also showed significant, unfavourable outcomes in patients with glucocorticoid‐exposed CM compared to glucocorticoid‐unexposed CM patients.

Conclusions

Previous glucocorticoid administration in NHNT patients seems to associate with 1‐year mortality after CM adjusted for possible confounders related to demographics, comorbidities and additional immunosuppressive medications. Serial CrAg screening might be appropriate for higher‐risk patients on glucocorticoids after further cost–benefit analyses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Meningitis, CryptococcalCryptococcusAIDS-Related Opportunistic InfectionsHIV InfectionsCryptococcus neoformansAdultHumansGlucocorticoidsRisk FactorsAntigens, Fungal

Stichwörter der Autor:innen

Cryptococcus neoformansCryptococcosisCryptococcus gattiiHIV-negative patientsglucocorticoidsnon-transplant patients

Substanzen

GlucocorticoidsAntigens, Fungal

Autor:innen und Institutionen

  • Division of Infectious Diseases, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Hospital Infantil de México, Federico Gomez, Mexico City, Mexico.
  • Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado, USA.
  • Division of Infectious Diseases, Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado, USA.
  • University of California-Davis, Medical Center, Sacramento, California, USA.
  • Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Albany, Georgia, USA.

ORCID-Profile: Luke Kim, George R Thompson, Daniel B Chastain, Jose Tuells, Andrés F Henao-Martínez

Zitieren

APA

Kim, L., Ferraz, C., Corbisiero, M. F., Gorvetzian, S., Franco-Paredes, C., Krsak, M., Shapiro, L., Thompson, G. R., Chastain, D. B., Tuells, J., & Henao-Martínez, A. F. (2024). Glucocorticoids as a risk factor for infection and adverse outcomes in non‐HIV and non‐transplant patients with cryptococcal meningitis. Mycoses, 67(3). https://doi.org/10.1111/myc.13709

Vancouver

Kim L, Ferraz C, Corbisiero MF, Gorvetzian S, Franco-Paredes C, Krsak M, et al. Glucocorticoids as a risk factor for infection and adverse outcomes in non‐HIV and non‐transplant patients with cryptococcal meningitis. Mycoses. 2024;67(3). doi:10.1111/myc.13709

BibTeX
@article{Kim2024,
  author = {Kim, Luke and Ferraz, Carolina and Corbisiero, Michaele Francesco and Gorvetzian, Sarah and Franco-Paredes, Carlos and Krsak, Martin and Shapiro, Leland and Thompson, George R and Chastain, Daniel B and Tuells, Jose and Henao-Martínez, Andrés F},
  title = {Glucocorticoids as a risk factor for infection and adverse outcomes in non‐HIV and non‐transplant patients with cryptococcal meningitis},
  journal = {Mycoses},
  year = {2024},
  volume = {67},
  number = {3},
  doi = {10.1111/myc.13709}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche